Trypanocidal and leishmanicidal properties of substitution-containing chalcones

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 4, 2003, Pages 1449-1451

  Lunardi, Fabiane ^a,b   Guzela, Michel ^a   Rodrigues, Andrea T ^a   Corrêa, Rogério ^a   Eger Mangrich, Iriane ^a,b   Steindel, Mário ^b   Grisard, Edmundo C ^b   Assreuy, Jamil ^b   Calixto, João B ^b   Santos, Adair R S ^b  

^a UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTILEISHMANIAL AGENT; ANTITRYPANOSOMAL AGENT; BENZNIDAZOLE; CHALCONE; FUNGIZON;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; GROWTH INHIBITION; IN VITRO STUDY; INHIBITION KINETICS; LEISHMANIA BRAZILIENSIS; MACROPHAGE; NONHUMAN; PARASITE DEVELOPMENT; PARASITE SURVIVAL; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

AMPHOTERICIN B; ANIMALS; CHALCONE; DOSE-RESPONSE RELATIONSHIP, DRUG; LEISHMANIA BRAZILIENSIS; NITROIMIDAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPANOSOMA CRUZI;

EID: 0037379518     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.4.1449-1451.2003     Document Type: Article

References (20)

1. Beirith, A., T. B. Creczynski-Pasa, V. R. Bonetti, M. Konzen, I. Seifriz, M. S. Paula, C. V. Franco, and J. B. Calixto. 1999. Antinociceptive properties and nitric oxide synthase inhibitory action of new ruthenium complexes. Eur. J. Pharmacol. 369:289-297.
2. Boveris, A. C., C. M. Hertig, and J. F. Turrens. 1986. Fumarate reductase and other mitochondrial activities in Trypanosoma cruzi. Mol. Biochem. Parasitol. 19:163-169.
3. Chen, M., S. B. Christensen, J. Blom, E. Lemmich, L. Nadelmann, K. Fich, T. G. Theander, and A. Kharazmi. 1993. Licochalcone A, a novel antiparasitic agent with potent activity against human pathogenic protozoan species of Leishmania. Antimicrob. Agents Chemother. 37:2550-2556.
4. Chen, M., T. G. Theander, S. B. Christensen, L. Hviid, L. Zhai, and A. Kharazmi. 1994. Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob. Agents Chemother. 38:1470-1475.
5. Chen, M., S. B. Christensen, T. G. Theander, and A. Kharazmi. 1994. Antileishmanial activity of licochalcone A in mice infected with Leishmania major and in hamsters infected with Leishmania donovani. Antimicrob. Agents Chemother. 38:1339-1344.
6. Chen, M., S. B. Christensen, L. Zhai, M. H. Rasmussen, T. G. Theander, S. Frekjaer, B. Steffansen, J. Davidsen, and A. Kharazmi. 1997. The novel oxygenated chalcone, 2,4-dimethoxy-4′-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo. J. Infect. Dis. 176:1327-1333.
7. Chen, M., L. Zhai, S. Brogger, S. B. Christensen, T. G. Theander, and A. Kharazmi. 2001. Inhibition of fumarate reductase in Leishmania major and L. donovani by chalcones. Antimicrob. Agents Chemother. 45:2023-2029.
8. Corrêa, R., M. A. S. Pereira, D. Buffon, L. Santos, V. Cechinel Filho, A. R. S. Santos, and R. J. Nunes. 2001. Antinociceptive properties of chalcones. Structure-activity relationships. Arch. Pharm. 334:332-334.
9. Costa-Pinto, D., L. S. Trindade, D. McMahon-Pratt, and Y. M. TraubCseko. 2001. Cellular trafficking in trypanosomatids: a new target for therapies? Int. J. Parasitol. 31:537-544.
10. Croft, S. L. 1997. The current status of antiparasite chemotherapy. Parasitology 114:83-96.
11. Dhar, D. N. 1981. The chemistry of chalcones and related compounds. Wiley-Interscience, New York, N.Y.
12. Dimmock, J. R., D. W. Elias, M. A. Beazely, and N. M. Kandepu. 1999. Bioactivities of chalcones. Curr. Med. Chem. 6:1125-1149.
13. Engers, H. D., R. Bergquist, and F. Moddaber. 1996. Progress on vaccines against parasites. Dev. Biol. Stand. 87:73-84.
14. Grisard, E. C., M. Steindel, J. J. Shaw, E. A. Y. Yshikawa, C. J. CarvalhoPinto, I. Eger-Mangrich, H. K. Toma, A. J. Romanha, and D. A. Campbell. 2000. Characterization of Leishmania sp. strains from autochthonous cases of human cutaneous leishmaniasis in Santa Catarina state, southern Brazil. Acta Trop. 74:89-93.
15. Modabber, F. 1993. Leishmaniasis, p. 77-87. In Tropical disease research progress 1991-92. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. World Health Organization, Geneva, Switzerland.
16. Opperdoes, F. R. 1994. The Trypanosomatidae: amazing organisms. J. Bioenerg. Biomembr. 26:145-146.
17. Van De Loosdrecht, A. A., E. Nennie, G. J. Ossenkoppele, R. H. Beelen, and M. N. Langenhuijse. 1991. Cell mediated cytotoxicity against U937 cells by human monocytes and macrophages in a modified colorimetric MTT assay. A methodological study. J. Immunol. Methods 141:15-22.
18. World Health Organization. 1991. Control of Chagas' disease. WHO Tech. Rep. Ser. 811:1-93.
19. Zhai, L., J. Blom, M. Chen, S. B. Christensen, and A. Kharazmi. 1995. The antileishmanial agent licochalcone A interferes with the function of parasite mitochondria. Antimicrob. Agents Chemother. 39:2742-2748.
20. Zhai, L., M. Chen, J. Blom, S. B. Christensen, T. G. Theander, and A. Kharazmi. 1999. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action. J. Antimicrob. Chemother. 43:793-803.